As the only
English-language, evidence-based, and SCIE-listed journal from the Asia-Pacific
region, the Journal of Evidence-Based Medicine (JEBM) is the official journal
of Cochrane China, a part of the international Cochrane Collaboration. The
Cochrane Collaboration is the world’s largest organization dedicated to
preparing and maintaining systematic reviews to help people make well-informed
decisions about healthcare interventions. Both Cochrane China and the Cochrane
Collaboration are committed to providing up-to-date and accurate information
about the effects of healthcare.
JEBM is co-edited
by Prof. Youping Li (Cochrane China) and Prof. Mike Clarke (Queen’s University
Belfast).
Aims and
Scope
The Journal of
Evidence-Based Medicine aims to present the latest research results and promote
the international understanding and development of evidence-based
decision-making, research, practice, and education.
Types of
Papers
The journal
welcomes submissions in the following fields: editorials, commentaries,
systematic reviews, clinical trials, methodologies, policy-making and
management, drug safety, education, patient safety, knowledge translation, and
guidelines. It encourages submissions from interdisciplinary studies, and all
manuscripts undergo blind peer review.
